Under the second Trump administration, CMMI has published far more detail about peformance of Enhancing Oncology Model ...

Metabolic syndrome severity is a meaningful marker of chronic kidney disease risk even when patients do not have other major ...

Chronic urticaria patients may have a higher risk of metabolic syndrome, with a pooled prevalence of 25.2% and an odds ratio ...

Medical school application and matriculation rates decreased for underrepresented racial and ethnic minorities in medicine ...

Despite the findings, existing data around cardiovascular risk in chronic lymphocytic leukemia (CLL) are limited, and more ...

Patients with acute respiratory failure who’ve been placed on a mechanical ventilator are less likely to be transferred to high-volume centers if they are uninsured, thus increasing their odds of ...

Ravi Vij, MD, MBA, discusses how measurable residual disease (MRD) testing is shaping treatment decisions in hematology and its potential to reduce costs and toxicity.

The definition of comprehensive non-small cell lung cancer (NSCLC) testing is rapidly evolving with new biomarkers and ...

New insights reveal how early intervention in radiologically isolated syndrome can delay multiple sclerosis (MS) onset and ...

In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases ...

In the final clip, James D. Chalmers, MBChB, PhD, notes that while the FDA approval of brensocatib is a milestone, questions remain on optimal patient selection, long-term benefits, and further ...

Renal denervation modestly lowers blood pressure, with durable long-term benefits, according to Deepak L. Bhatt, MD, MPH, MBA ...